People: GlaxoSmithKline PLC (GLAXF.PK)
21 May 2013
Mr. Patrick Vallance is President - Pharmaceuticals R&D of Glaxosmithkline Plc. He was appointed President, Pharmaceuticals R&D, in January 2012. Prior to his appointment he was Senior Vice President, Medicines Discovery and Development. Patrick joined the company in 2006 as Head of Drug Discovery. Prior to joining GSK Patrick was a clinical academic at University College London. Patrick is a member of the Board of the Agency for Science, Technology & Research (A*STAR) and is a director of Genome Research Limited. He is also a member of the International Scientific Advisory Board of the Cambridge Institute for Medical Research.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|